| Adenosine monophosphate–activated kinase and its key role in catabolism: Structure, regulation, biological activity, and pharmacological activation S Krishan, DR Richardson, S Sahni Molecular pharmacology 87 (3), 363-377, 2015 | 88 | 2015 |
| Gene of the month: BECN1 S Sahni, AM Merlot, S Krishan, PJ Jansson, DR Richardson Journal of Clinical Pathology 67 (8), 656-660, 2014 | 79 | 2014 |
| Amp kinase (prkaa1) S Krishan, DR Richardson, S Sahni Journal of clinical pathology 67 (9), 758-763, 2014 | 57 | 2014 |
| The anticancer agent, di-2-pyridylketone 4, 4-dimethyl-3-thiosemicarbazone (Dp44mT), up-regulates the AMPK-dependent energy homeostasis pathway in cancer cells S Krishan, DR Richardson, S Sahni Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (12), 2916-2933, 2016 | 44 | 2016 |
| Iron metabolism and autophagy: a poorly explored relationship that has important consequences for health and disease S Krishan, PJ Jansson, E Gutierrez, DJR Lane, DES Richardson, S Sahni Nagoya journal of medical science 77 (1-2), 1, 2015 | 27 | 2015 |
| Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells S Krishan, S Sahni, LYW Leck, PJ Jansson, DR Richardson Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (5), 165657, 2020 | 21 | 2020 |
| The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis S Krishan, S Sahni, DR Richardson Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (12), 165970, 2020 | 10 | 2020 |
| NDRG1 as a molecular target to inhibit the epithelial–mesenchymal transition: the case for developing inhibitors of metastasis S Sahni, S Krishan, DR Richardson Future medicinal chemistry 6 (11), 1241-1244, 2014 | 9 | 2014 |
| Gene of the month S Krishan, DR Richardson, S Sahni AMP kinase (PRKAA1) J Clin Pathol 67 (9), 758-763, 2014 | 7 | 2014 |
| The use of iron chelators in biocidal compositions: evaluation of patent, WO2014059417A1 S Sahni, S Krishan, D Palanimuthu, DR Richardson Expert Opinion on Therapeutic Patents 25 (3), 367-372, 2015 | 1 | 2015 |
| Adenosine Monophosphate Activated Kinase (AMPK) and its Key Role in Catabolism: Structure, Regulation, Biological Activity and Pharmacological Activation. S Krishan, DR Richardson, S Sahni Molecular Pharmacology, 2014 | 1 | 2014 |
| Role of AMPK in the Cytotoxic Effects of Anti-Tumour Agent, Dp44mT, in Pancreatic Cancer S KRISHAN | | 2019 |
| Abstract B142: The anticancer agent Dp44mT upregulates the AMPK-dependent energy homeostasis pathway in cancer cells S Krishan, S Sahni, DR Richardson Molecular Cancer Therapeutics 17 (1_Supplement), B142-B142, 2018 | | 2018 |
| Targeting autophagy in antitumor agent design: furthering the ‘lysosomal love’strategy S Sahni, Z Kovacevic, DS Kalinowski, M Huang, S Menezes, S Krishan, ... Future Medicinal Chemistry 8 (7), 727-729, 2016 | | 2016 |
